The excellent growth rate of the Kenyan pharmaceutical industry offers opportunities for exporters and manufacturers to establish their products and services in East Africa.

Currently, Kenya is the largest producer of pharmaceutical products in the common market for Eastern and Southern Africa (COMESA) region; catering to about 50% of the region.

Kenya’s prescription pharmaceuticals market is worth over $500 million. Prescription drugs account for around 78% of the market value.

Pharmacor Ltd. is a wholly owned subsidiary of Alkem in Kenya. To tap the market in various therapeutic segments such as chronic and acute segments, we have planned to set up a strong marketing & distribution network for our products.

Pharmacor Ltd. has been established as one of Kenya’s strongest player in healthcare and as a pioneer in world-class quality products. Pharmacor is a fully integrated pharmaceutical business entity, that’s capable of marketing and distributing products on its own.